Disposition of 16574 shares by Hamilton Alex P. of Mangoceuticals Common at 0.31 subject to Rule 16b-3
| MGRX Stock | 2.42 0.31 14.69% |
Slightly above 55% of Mangoceuticals, Common's investors are presently thinking to get in. The analysis of overall sentiment of trading Mangoceuticals, Common Stock stock suggests that some investors are interested at this time. Mangoceuticals, Common's investing sentiment can be driven by a variety of factors including economic data, Mangoceuticals, Common's earnings reports, geopolitical events, and overall market trends.
Mangoceuticals, | Build AI portfolio with Mangoceuticals, Stock |
Filed transaction by Mangoceuticals Common Stock Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Mangoceuticals, Common Fundamental Analysis
We analyze Mangoceuticals, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mangoceuticals, Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mangoceuticals, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Mangoceuticals, Common is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Mangoceuticals, Common Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mangoceuticals, Common stock to make a market-neutral strategy. Peer analysis of Mangoceuticals, Common could also be used in its relative valuation, which is a method of valuing Mangoceuticals, Common by comparing valuation metrics with similar companies.
Peers
Mangoceuticals, Common Related Equities
| BFRG | Bullfrog | 1.70 |
| ||
| EUDA | EUDA Health | 3.37 |
| ||
| FOXO | FOXO Technologies | 8.51 |
|
Additional Tools for Mangoceuticals, Stock Analysis
When running Mangoceuticals, Common's price analysis, check to measure Mangoceuticals, Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mangoceuticals, Common is operating at the current time. Most of Mangoceuticals, Common's value examination focuses on studying past and present price action to predict the probability of Mangoceuticals, Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mangoceuticals, Common's price. Additionally, you may evaluate how the addition of Mangoceuticals, Common to your portfolios can decrease your overall portfolio volatility.